Matches in Nanopublications for { ?s ?p "[Treatment of NSCLC cells with antisense S-oligonucleotides or vector-based small interfering RNAs of COX17 suppressed expression of COX17 and also the activity of CCO, and suppressed growth of the cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP836046.RAQrZ5K3YgCNmw9nfGwNwI4ry8mUVY0eE57FsT_OIB53I130_assertion description "[Treatment of NSCLC cells with antisense S-oligonucleotides or vector-based small interfering RNAs of COX17 suppressed expression of COX17 and also the activity of CCO, and suppressed growth of the cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836046.RAQrZ5K3YgCNmw9nfGwNwI4ry8mUVY0eE57FsT_OIB53I130_provenance.
- NP836050.RALMSMZ-QHaolFhX2qK899Dw_OJRlzt383KKXP_Q8lI8g130_assertion description "[Treatment of NSCLC cells with antisense S-oligonucleotides or vector-based small interfering RNAs of COX17 suppressed expression of COX17 and also the activity of CCO, and suppressed growth of the cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836050.RALMSMZ-QHaolFhX2qK899Dw_OJRlzt383KKXP_Q8lI8g130_provenance.